Biodesix Adding Immunotherapy Test to Lung Cancer Portfolio – GenomeWeb
|
Biodesix Adding Immunotherapy Test to Lung Cancer Portfolio
GenomeWeb NEW YORK (GenomeWeb) – Molecular diagnostics firm Biodesix plans this year to launch a proteomic test for guiding immunotherapy in non-small cell lung cancer patients as it continues to build out its lung cancer offerings. The company aims to release … |
